Adiponectin (AD) reduces the risk of hypertension because of its anti-inflammatory, antiatherogenic, and insulin-sensitizing properties. The study described here was done to evaluate the interrelationships of AD, blood pressure (BP), obesity, body-fat distribution, puberty, and insulin resistance in a selected group of children.
Brambilla, P., Antolini, L., Street, M., Giussani, M., Galbiati, S., Valsecchi, M., et al. (2013). Adiponectin and hypertension in normal-weight and obese children. AMERICAN JOURNAL OF HYPERTENSION, 26(2), 257-264 [10.1093/ajh/hps033].
Adiponectin and hypertension in normal-weight and obese children
Brambilla, P;ANTOLINI, LAURA;VALSECCHI, MARIA GRAZIA;STELLA, ANDREA;GENOVESI, SIMONETTA CARLA
2013
Abstract
Adiponectin (AD) reduces the risk of hypertension because of its anti-inflammatory, antiatherogenic, and insulin-sensitizing properties. The study described here was done to evaluate the interrelationships of AD, blood pressure (BP), obesity, body-fat distribution, puberty, and insulin resistance in a selected group of children.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
